71.45
price down icon0.75%   -0.54
after-market Handel nachbörslich: 71.00 -0.45 -0.63%
loading
Schlusskurs vom Vortag:
$71.99
Offen:
$71.54
24-Stunden-Volumen:
4.00M
Relative Volume:
4.64
Marktkapitalisierung:
$2.30B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.99M
KGV:
-23.84
EPS:
-2.9966
Netto-Cashflow:
$-24.94M
1W Leistung:
+42.50%
1M Leistung:
+46.35%
6M Leistung:
+41.51%
1J Leistung:
+66.94%
1-Tages-Spanne:
Value
$69.87
$73.94
1-Wochen-Bereich:
Value
$48.29
$73.97
52-Wochen-Spanne:
Value
$36.61
$73.97

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Name
Firmenname
Soleno Therapeutics Inc
Name
Telefon
650-213-8444
Name
Adresse
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
SLNO's Discussions on Twitter

Vergleichen Sie SLNO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SLNO
Soleno Therapeutics Inc
71.45 2.30B 0 -38.99M -24.94M -2.9966
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-05 Fortgesetzt Stifel Buy
2024-12-02 Bestätigt Robert W. Baird Outperform
2024-12-02 Bestätigt Stifel Buy
2024-09-03 Eingeleitet H.C. Wainwright Buy
2024-05-10 Eingeleitet Robert W. Baird Outperform
2024-02-05 Eingeleitet Piper Sandler Overweight
2024-01-23 Eingeleitet Stifel Buy
2023-11-21 Fortgesetzt Guggenheim Buy
2020-09-29 Eingeleitet Guggenheim Buy
2020-01-10 Eingeleitet Craig Hallum Buy
2019-12-23 Eingeleitet Oppenheimer Outperform
2018-02-13 Bestätigt Maxim Group Buy
Alle ansehen

Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten

pulisher
07:29 AM

Soleno Therapeutics CCO sells shares worth $2.48m - Investing.com

07:29 AM
pulisher
07:29 AM

Soleno therapeutics director Matthew Pauls sells $424,797 in stock - Investing.com

07:29 AM
pulisher
07:27 AM

Soleno Therapeutics CFO sells $4.88 million in stock - Investing.com

07:27 AM
pulisher
07:21 AM

Soleno Therapeutics exec sells shares worth $9.5 million - Investing.com India

07:21 AM
pulisher
07:13 AM

Soleno Therapeutics CEO sells $35.3 million in stock - Investing.com

07:13 AM
pulisher
07:13 AM

Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock - Investing.com

07:13 AM
pulisher
07:10 AM

Soleno Therapeutics Executives Sell Shares - TradingView

07:10 AM
pulisher
08:01 AM

Soleno stock price target raised to $100 at H.C. Wainwright - Investing.com

08:01 AM
pulisher
05:32 AM

Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock By Investing.com - Investing.com South Africa

05:32 AM
pulisher
05:30 AM

Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock - Investing.com India

05:30 AM
pulisher
Mar 30, 2025

Soleno Therapeutics Stock (SLNO) Surges on FDA Green Light for PWS Treatment - Markets Insider

Mar 30, 2025
pulisher
Mar 29, 2025

Why Soleno Therapeutics Inc. (SLNO) Went Up Last Week? - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

10 Stocks Outperform Broader Market Last Week - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

Soleno Therapeutics (NASDAQ:SLNO) Trading 3.9% Higher on Analyst Upgrade - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN

Mar 29, 2025
pulisher
Mar 29, 2025

Vivo opportunity sells $124 million in Soleno Therapeutics stock By Investing.com - Investing.com South Africa

Mar 29, 2025
pulisher
Mar 29, 2025

Why Soleno Therapeutics Inc. (SLNO) Went Up On Friday? - MSN

Mar 29, 2025
pulisher
Mar 29, 2025

Guggenheim raises Soleno Therapeutics stock target to $81 By Investing.com - Investing.com Canada

Mar 29, 2025
pulisher
Mar 28, 2025

Major Shareholder Sells Massive Stake in Soleno Therapeutics! - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Vivo opportunity sells $124 million in Soleno Therapeutics stock - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Stifel raises Soleno stock target to $108 after FDA approval By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

PANTHERx® Rare Selected by Soleno Therapeutics for the Distribution of VYKAT™ XR - PR Newswire

Mar 28, 2025
pulisher
Mar 28, 2025

Stifel raises Soleno stock target to $108 after FDA approval - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Soleno Therapeutics price target raised to $108 from $74 at Stifel - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

FDA Approves First Therapy To Treat Hyperphagia in Prader-Willi Syndrome - Technology Networks

Mar 28, 2025
pulisher
Mar 28, 2025

Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday? - Insider Monkey

Mar 28, 2025
pulisher
Mar 28, 2025

Soleno Therapeutics Joins Elite Club Of Stocks With RS Ratings Over 90 - Investor's Business Daily

Mar 28, 2025
pulisher
Mar 28, 2025

FDA Greenlights Soleno Therapeutics’ VYKAT XR for PWS Hyperphagia - geneonline.com

Mar 28, 2025
pulisher
Mar 27, 2025

Oppenheimer lifts Soleno Therapeutics stock target to $105 By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease - Mugglehead

Mar 27, 2025
pulisher
Mar 27, 2025

Biotech Zooms Into Breakout Zone On Hard-Fought Approval - Investor's Business Daily

Mar 27, 2025
pulisher
Mar 27, 2025

First Prader-Willi treatment Vykat XR FDA-approved: Soleno soars - BioWorld MedTech

Mar 27, 2025
pulisher
Mar 27, 2025

Drugmaker Soleno Soars on Approval to Treat Never Ending Hunger - Bloomberg.com

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Therapeutics: In No Rush To Join Buying Frenzy Despite Vykat Approval (SLNO) - Seeking Alpha

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno wins FDA approval for Prader-Willi hyperphagia treatment - Yahoo

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Shares Are Up Today: What's Going On? - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

FDA Approves Soleno Therapeutics’ Vykat XR for Hyperphagia in Patients with Prader-Willi Syndrome - Pharmaceutical Executive

Mar 27, 2025
pulisher
Mar 27, 2025

Baird Raises Soleno Therapeutics' Price Target to $102 From $72, Outperform Rating Maintained - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Therapeutics: A Breakthrough in Rare Disease Treatment - RagingBull

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno’s Vykat Gains First Prader-Willi Syndrome Approval, Rivals To Follow - insights.citeline.com

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno stock skyrockets on FDA drug approval - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno breaks through with FDA nod for Prader-Willi syndrome treatment Vykat XR - FiercePharma

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno jumps as analysts say US nod for rare disease drug transforms treatment options - MSN

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Therapeutics execs reap stock windfall after FDA approves rare disease drugSan Francisco Business Times - The Business Journals

Mar 27, 2025
pulisher
Mar 27, 2025

Piper Sandler maintains $93 target on Soleno Therapeutics stock By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Skyrockets 40% on FDA Nod for VYKAT XR - Wall Street Pit

Mar 27, 2025
pulisher
Mar 27, 2025

Concentrix Posts Better-Than-Expected Earnings, Joins Soleno Therapeutics, Petco Health and Wellness, MillerKnoll And Other Big Stocks Moving Higher On Thursday - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

Stifel maintains Soleno Therapeutics buy rating post FDA nod By Investing.com - Investing.com Australia

Mar 27, 2025
pulisher
Mar 27, 2025

Behind the Scenes of Soleno Therapeutics's Latest Options Trends - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

SLNO stock touches 52-week high at $66.16 amid robust growth - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

Stifel maintains Soleno Therapeutics buy rating post FDA nod - Investing.com India

Mar 27, 2025

Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Kapitalisierung:     |  Volumen (24h):